AQUESTIVE THERAPEUTICS INC (AQST) Stock Balance Sheet
NASDAQ:AQST • US03843E1047
Current stock price
4.175 USD
+0.16 (+3.86%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 121.17M | 71.55M | 23.87M | 27.27M | 28.02M | |||
| Receivables | 17.76M | 7.34M | 8.47M | 4.70M | 12.12M | |||
| Inventories | 6.17M | 6.04M | 6.77M | 5.78M | 4.04M | |||
| Other Current Assets | 4.17M | 3.29M | 1.85M | 2.13M | 3.08M | |||
| Total Current Assets | 149.27M | 88.22M | 40.97M | 39.89M | 47.26M | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.51M | 8.98M | 9.74M | 9.30M | 7.78M | |||
| Intangibles | 0.00 | 0.00 | 1.28M | 1.44M | 50.00K | |||
| Other Non-Current Assets | 642.00K | 1.22M | 1.44M | 1.45M | 900.00K | |||
| Total Non-Current Assets | 11.16M | 13.20M | 16.45M | 17.18M | 14.73M | |||
| TOTAL ASSETS | 160.43M | 101.42M | 57.42M | 57.07M | 61.99M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 10.99M | 1.11M | 944.00K | 18.70M | 2.03M | |||
| Accrued Expenses | 5.66M | 6.42M | 6.89M | 8.22M | 9.64M | |||
| Accounts Payable | 29.86M | 10.29M | 8.93M | 9.95M | 8.31M | |||
| Other Current Liabilities | 1.09M | 1.05M | 1.55M | 2.66M | 1.99M | |||
| Total Current Liabilities | 47.61M | 18.86M | 18.31M | 39.53M | 21.96M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 115.48M | 115.35M | 105.84M | 33.45M | 51.55M | |||
| Other Non-Current Liabilities | 31.00M | 27.37M | 39.76M | 102.65M | 70.61M | |||
| Total Non-Current Liabilities | 146.48M | 142.72M | 145.60M | 136.09M | 122.17M | |||
| TOTAL LIABILITIES | 194.09M | 161.58M | 163.91M | 175.62M | 144.13M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -447.00M | -363.21M | -319.08M | -311.21M | -256.80M | |||
| Additional Paid In Capital | 413.21M | 302.97M | 212.52M | 192.60M | 174.62M | |||
| Common Shares | 122.00K | 91.00K | 69.00K | 60.00K | 40.00K | |||
| Shares Outstanding | 122.04M | 91.41M | 68.53M | 54.83M | 41.23M | |||
| Tangible Book Value per Share | -0.28 | -0.66 | -1.57 | -2.19 | -1.99 | |||
| Total Shareholders' Equity | -33.66M | -60.16M | -106.49M | -118.55M | -82.13M | |||
| TOTAL LIABILITIES AND EQUITY | 160.43M | 101.42M | 57.42M | 57.07M | 61.99M | |||
| Statistics | ||||||||
| Debt/Equity | -3.43 | -1.92 | -0.99 | -0.28 | -0.63 | |||
| Current Ratio | 3.14 | 4.68 | 2.24 | 1.01 | 2.15 | |||
| Return On Assets (ROA) | -52.23% | -43.52% | -13.71% | -95.34% | -113.79% | |||
| Return On Equity (ROE) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21